Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  Epigenetics  >>  SensoLyte® 520 HDAC Activity Assay Kit *Fluorimetric*

Product Name SensoLyte® 520 HDAC Activity Assay Kit *Fluorimetric*
Size 1 kit
Catalog # AS-72084
US$ $435
Description

Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the treatment of cancer and neurodegenerative diseases. The SensoLyte® 520 HDAC Activity Assay Kit provides a convenient, two-step homogeneous procedure for measuring HDAC activity using a fluorogenic substrate. In the first step, an acetylated substrate is incubated with HDAC containing samples. Deacetylation of substrate sensitizes it, so that, in the second step mixing with the HDAC developer generates a fluorophore, which can then be detected at Ex/Em= 490 nm/520 nm. The substrate included in the kit is cell-permeable, and the assay can be used to measure HDAC activity directly in cell culture in a 96-well plate without a time-consuming cell extraction step. This kit also can be used for high throughput screening of HDAC inhibitors using extracts or purified enzymes. The long wavelength fluorescence of HDAC 520 substrate is less interfered by the autofluorescence of cell components and test compounds. The kit contains: • HDAC 520 substrate • Deacetylated reference standard for calibration • HeLa nuclear extract • Assay buffer • Cell lysis buffer • HDAC developer • Trichostatin A (HDAC inhibitor) • A detailed protocol.

100 assays (96-well plate)

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Poster
Flyer
Storage -20°C
Product Citations Ehnert, S. et al. (2012). Transforming growth factor beta1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med 10, 101. doi: 10.1186/1741-7015-10-101
Kang, H. et al. (2011). A novel isoform of human LZIP negatively regulates the transactivation of the glucocorticoid receptor. Mol Endocrinol 23, 1746.
Park, JH. et al. (2012). A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells. Invest New Drugs 30, 1887. doi: 10.1007/s10637-011-9752-z.
     
  < Back